Mindfulness techniques target present-moment awareness and nonjudgmental observation of thoughts and sensations. Mindfulness-Based Relapse Prevention combines meditation training with cognitive-behavioral relapse strategies to help people notice cravings without acting on them. Sarah Bowen of the University of Washington and colleagues have been central to adapting and testing this approach, while G. Alan Marlatt of the University of Washington contributed foundational relapse-prevention theory that informed the integration.
Evidence from clinical studies and reviews
Randomized clinical trials led by Sarah Bowen of the University of Washington reported that groups receiving mindfulness-based relapse prevention experienced lower rates of substance use and longer times to relapse than comparison groups in some studies. Judson Brewer of Brown University and his team have provided mechanistic evidence linking mindfulness practice to reduced craving and habit-driven behavior, using behavioral and neural measures. Systematic reviews and narrative syntheses by researchers such as Lidia Zgierska of the University of Wisconsin-Madison characterize the evidence as promising but heterogeneous, noting positive effects on craving, substance use, and mental-health symptoms across several controlled trials but also variability in study quality, sample size, and follow-up duration. The National Institute on Drug Abuse recognizes mindfulness approaches as an emerging, potentially useful adjunct to standard treatment rather than a standalone cure.
How mindfulness helps, and important limits
Mindfulness appears to work by increasing awareness of internal triggers, decoupling automatic responses from temporary cravings, and reducing stress reactivity, which commonly precipitates relapse. Clinically, patients report greater ability to tolerate discomfort and to choose alternative coping behaviors. Cultural and territorial context matters: mindfulness skills may integrate differently with local practices and beliefs, and programs adapted for Indigenous, urban, or low-resource communities require cultural sensitivity and accessible delivery. Environmental factors such as housing instability, ongoing exposure to substances, and limited access to trained instructors can blunt effectiveness.
Evidence supports mindfulness as a useful adjunct for preventing relapse, especially when combined with psychosocial supports and medical treatment, but it is not uniformly effective for all populations. High-quality, longer-term trials and culturally adapted implementations are still needed to define who benefits most and how to scale programs equitably.